MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gage, M. J.
Right arrow Articles by Smith, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gage, M. J.
Right arrow Articles by Smith, T. J.

Vol. 61, Issue 4, 936-936, April 2002

The Virally Encoded Fungal Toxin KP4 Specifically Blocks L-Type Voltage-Gated Calcium Channels

Matthew J. Gage, Stanley G. Rane, Gregory H. Hockerman, and Thomas J. Smith

Donald Danforth Plant Science Center, St. Louis, Missouri (M.J.G., T.J.S.); Fujisawa Research Institute of America, Northwestern University/Evanston Research Park, Evanston, Illinois (S.G.R.); Medicinal Chemistry/Molecular Pharmacology, Purdue University, West Lafayette, Indiana (G.H.H.)

KP4 is a virally encoded fungal toxin secreted by the P4 killer strain of Ustilago maydis. Previous studies demonstrated that this toxin inhibits growth of the target fungal cells by blocking calcium uptake rather than forming channels, as had been suggested previously. Unexpectedly, this toxin was also shown to inhibit voltage-gated calcium channel activity in mammalian cells. We used whole-cell patch-clamp techniques to further characterize this activity against mammalian cells. KP4 is shown to specifically block L-type calcium channels with weak voltage dependence to the block. Because KP4 activity is abrogated by calcium, KP4 probably binds competitively with calcium to the channel exterior. Finally, it is shown that chemical reagents that modify lysine residues reduce KP4 activity in both patch-clamp experiments on mammalian cells and in fungal killing assays. Because the only lysine residue is K42, this residue seems to be crucial for both mammalian and fungal channel activity. Our results defining the type of mammalian channel affected by this fungal toxin further support our contention that KP4 inhibits fungal growth by blocking transmembrane calcium flux through fungal calcium channels, and imply a high degree of structural homology between these fungal and mammalian calcium channels.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Plant Physiol.Home page
R. G. Spelbrink, N. Dilmac, A. Allen, T. J. Smith, D. M. Shah, and G. H. Hockerman
Differential Antifungal and Calcium Channel-Blocking Activity among Structurally Related Plant Defensins
Plant Physiology, August 1, 2004; 135(4): 2055 - 2067.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Liu, N. Hilliard, and G. H. Hockerman
Cav1.3 Is Preferentially Coupled to Glucose-Induced [Ca2+]i Oscillations in the Pancreatic {beta} Cell Line INS-1
Mol. Pharmacol., May 1, 2004; 65(5): 1269 - 1277.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Kolski-Andreaco, H. Tomita, V. G. Shakkottai, G. A. Gutman, M. D. Cahalan, J. J. Gargus, and K. G. Chandy
SK3-1C, a Dominant-negative Suppressor of SKCa and IKCa Channels
J. Biol. Chem., February 20, 2004; 279(8): 6893 - 6904.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Liu, N. Dilmac, N. Hilliard, and G. H. Hockerman
Cav1.3 Is Preferentially Coupled to Glucose-Stimulated Insulin Secretion in the Pancreatic beta -Cell Line INS-1
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 271 - 278.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics